These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Weight reduction with chlorphenetermine and phenmetrazine in obese psychiatric patients during chlorpromazine therapy. Sletten IW; Ognjanov V; Menendez S; Sundland D; el-Toumi A Curr Ther Res Clin Exp; 1967 Nov; 9(11):570-5. PubMed ID: 4965506 [No Abstract] [Full Text] [Related]
4. Weight reduction with phenmetrazine and chlorphentermine a double-blind study. Hadler AJ Curr Ther Res Clin Exp; 1967 Nov; 9(11):563-9. PubMed ID: 4965505 [No Abstract] [Full Text] [Related]
5. [Controlled clinical trials of a new appetite-inhibiting drug]. Bani G; Barba C; Ricci G Clin Ter; 1968 Oct; 47(2):161-74. PubMed ID: 5702726 [No Abstract] [Full Text] [Related]
6. [Phentermine resinate in obesity. Clinical trial of Mirapront in adipose children]. Spranger J Munch Med Wochenschr; 1965 Sep; 107(38):1833-4. PubMed ID: 5323498 [No Abstract] [Full Text] [Related]
7. Chlorphentermine and phenmetrazine compared: weight reduction, side effects and psychological change. Sletten IW; Sundland D; Pichardo J; Viamontes G Mo Med; 1967 Nov; 64(11):927-9. PubMed ID: 6056101 [No Abstract] [Full Text] [Related]
8. [Regulation of appetite in obese subjects by means of neutrotropic drugs]. Gamski M; Komarnicka R Pol Tyg Lek; 1968 Oct; 23(44):1688-90. PubMed ID: 5701464 [No Abstract] [Full Text] [Related]
9. [Controled trial of an anorectic (An 448) in the treatment, of childhood obesity]. Canlorbe P; Borniche P; Toublanc JE Nouv Presse Med; 1976 Apr; 5(16):1061-2. PubMed ID: 775433 [No Abstract] [Full Text] [Related]
10. [Studies on the usefulness of various preparations inhibiting hunger sensation]. Krotkiewski M; Bielecka J; Ruzyllo E Pol Tyg Lek; 1968 Sep; 23(34):1277-80. PubMed ID: 5722527 [No Abstract] [Full Text] [Related]
12. Comparison of continuous and intermittent anorectic therapy in obesity. Munro JF; MacCuish AC; Wilson EM; Duncan LJ Br Med J; 1968 Feb; 1(5588):352-4. PubMed ID: 15508204 [No Abstract] [Full Text] [Related]
13. Double-blind trial of anorectic agents. Sproule BC Med J Aust; 1969 Feb; 1(8):394-5. PubMed ID: 4889477 [No Abstract] [Full Text] [Related]
14. [Model for clinico-pharmacological experimentation with an appetite depressant. Clinical trial with a delayed-action preparation]. Strata A; Cucurachi L; Cucurachi P; Dell'anna A; Zuliani U Clin Ter; 1968 Mar; 44(6):495-516. PubMed ID: 4899457 [No Abstract] [Full Text] [Related]
15. Obesity-depression: clinical evaluation with a new anorexigenic agent. Kornhaber A Psychosomatics; 1973; 14(3):162-7. PubMed ID: 4604838 [No Abstract] [Full Text] [Related]
16. Clinical aspects of the treatment of obesity by drugs: a review. Munro JF Int J Obes; 1979; 3(2):171-80. PubMed ID: 393645 [TBL] [Abstract][Full Text] [Related]
17. [Therapeutic effect of various appetite depressants under controlled conditions]. Kreze A; Toman A Bratisl Lek Listy; 1973; 59(4):406-12. PubMed ID: 4751882 [No Abstract] [Full Text] [Related]
18. [Effect of Cafilon in the treatment of obesity (author's transl)]. Honzák R; Rath R; Vondra K Cesk Gastroenterol Vyz; 1976 Apr; 30(3):155-61. PubMed ID: 1277334 [No Abstract] [Full Text] [Related]
19. Weight control in obese diabetics. A comparative trial of Filon and phenmetrazine. Buckle RM; Silverstone JT Br J Clin Pract; 1966 Jul; 20(7):363-5. PubMed ID: 5940969 [No Abstract] [Full Text] [Related]
20. [Evaluation of an "anorexic" drug (phentermine-resin) in the treatment of obesity]. Benedetti A; Busonera G; Cattano G Policlinico Prat; 1967 Nov; 74(48):1613-9. PubMed ID: 5611163 [No Abstract] [Full Text] [Related] [Next] [New Search]